PROCEPT BioRobotics shares are trading lower after Leerink Partners downgraded the stock from Outperform to Market Perform rating and lowered its price target from $31 to $29.

Benzinga Newsdesk www.benzinga.com Negative 97.3%

Neg 97.3% Neu 0% Pos 0%

Comments

No comments yet. Be the first!